ICOTYDE

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Mar 17, 2026

   3 mo ago

2. Today

3. Exclusivity ends · NCE

   New chemical entity exclusivity (5 years)

   Mar 17, 2031

   in 4 yr 10 mo

4. Patent 12552836 expires

   Listed drug substance patent expiration.

   Jul 12, 2039

   in 13 yr 3 mo

5. Patent 11845808 expires

   Listed drug substance patent expiration.

   Jan 14, 2041

   in 14 yr 9 mo

6. Patent 11939361 expires

   Listed drug product patent expiration.

   Nov 19, 2041

   in 15 yr 8 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (1)

• NCENew chemical entity exclusivity (5 years)

  Mar 17, 2031

  in 4 yr 10 mo

Listed patents (3)